日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load

多发性骨髓瘤中的循环肿瘤细胞是骨髓高危基因组改变和肿瘤负荷的复合生物标志物。

Fokkema, Cathelijne; Bertamini, Luca; de Jong, Madelon M E; Tahri, Sabrin; Hofste Op Bruinink, Davine; Kellermayer, Zoltan; Papazian, Natalie; den Hollander, Chelsea; Vermeulen, Michael P W; Stoetman, Elodie C G; van Beek, Gregory; Hoogenboezem, Remco; van der Velden, Vincent H J; Hulin, Cyrille; Perrot, Aurore; Moreau, Philippe; Rowe, Melissa; Vieyra, Diego; Carson, Robin; van Duin, Mark; Sanders, Mathijs A; Broijl, Annemiek; Sonneveld, Pieter; Cupedo, Tom

Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone

循环肿瘤细胞可预测接受达雷妥尤单抗、硼替佐米、来那度胺和地塞米松治疗的多发性骨髓瘤患者的预后

Bertamini, Luca; Fokkema, Cathelijne; Rodriguez-Otero, Paula; van Duin, Mark; Terpos, Evangelos; D'Agostino, Mattia; van der Velden, Vincent H J; van de Donk, Niels W C J; Delforge, Michel; Driessen, Christoph; Hajek, Roman; Einsele, Hermann; Vangsted, Annette; Vieyra, Diego; Attar, Ricardo; Sitthi-Amorn, Anna; Carson, Robin; Schjesvold, Fredrik; Robak, Pawel; Beksac, Meral; Spencer, Andrew; Broijl, Annemiek; Cupedo, Tom; Moreau, Philippe; Boccadoro, Mario; Sonneveld, Pieter

Proteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers

GSD Ia 和 Ib 患者血清和肝脏蛋白质组学分析:对并发症机制和循环生物标志物的深入了解

Xiao, Ruiqi; Gross-Valle, Candelas; Gerding, Albert; Thorne, Adam M; Oosterveer, Maaike H; Derks, Terry G J; de Meijer, Vincent E; Heiner-Fokkema, M Rebecca; Bakker, Barbara M; Wolters, Justina C

Inner Branched Endovascular Repair of a Post-Type B Dissection Aneurysm Previously Treated With a Nellix in Both Lumens: Making the Most of a Complex Situation

对先前已在双腔内使用 Nellix 支架治疗的 B 型夹层后动脉瘤进行内分支血管内修复:充分利用复杂情况

Fokkema, Talje M; Alrawi, Wajdi; Åstrand, Håkan; Lind, Robert C

Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of life

临终癌症患者的大血管肿瘤浸润和循环肿瘤细胞簇动态变化

Kelley Newcomer ,Alessandro Bifolco ,Sarah Reeves ,Giada Pontecorvi ,Simran Asawa ,Magdalena K Sznurkowska ,Manuel Nüesch ,Lauren L Ozimski ,Louisa Bolm ,Malte Maria Sieren ,Lukas Müller ,Zhikai Chi ,William Gasper ,Megan B Wachsmann ,William Moore ,Xue Zheng ,Angelique Fokkema ,Alexander Ring ,Bich Doan Nguyen-Sträuli ,Selina Budinjas ,Meike Ten Winkel ,Benedikt Färber ,Abbas Zaki ,Nafeesah Fatimah ,Elena Crecca ,John D Karalis ,Raghav Chandra ,Hillary Prince ,Kristina L Goff ,Sung-Hee Choi ,Carol Abousaab ,Song Zhang ,Suzanne Cole ,Kathryn Naumann ,Tobias Keck ,Patricio M Polanco ,Ana Gvozdenovic ,Ilona Krol ,Francesc Castro-Giner ,Carlos Arteaga ,Herbert J Zeh ,Roman Kloeckner ,Dario Ghersi ,Nicola Aceto ,Matteo Ligorio

Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma.

骨髓瘤中基因型定义的多克隆浆细胞的异常单细胞表型及其临床意义。

Da Vià Matteo Claudio, Lazzaroni Francesca, Matera Antonio, Marella Alessio, Maeda Akihiro, De Magistris Claudio, Pettine Loredana, Solimando Antonio Giovanni, Desantis Vanessa, Peretti Giuseppe M, Mangiavini Laura, Giorgino Riccardo, Fabris Sonia, Pioggia Stefania, Marchetti Alfredo, Barbieri Marzia, Lonati Silvia, Cattaneo Alessandra, Tornese Marta, Scopetti Margherita, Calvi Emanuele, Latifinavid Nayyer, Castellano Giancarlo, Torricelli Federica, Neri Antonino, Fokkema Cathelijne, Cupedo Tom, Lionetti Marta, Passamonti Francesco, Bolli Niccolò

First-in-human administration of [(161)Tb]Tb-SibuDAB and comparative dosimetry with standard [(177)Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia study

作为 PROGNOSTICS Ia 期研究的一部分,首次在人体内使用 [(161)Tb]Tb-SibuDAB,并与标准 [(177)Lu]Lu-PSMA-I&T 进行剂量比较。

Chirindel, Alin; Nicolas, Guillaume P; Westerbergh, Frida; McDougall, Lisa; Schmid, David E; Geistlich, Susanne; Tschan, Viviane J; Busslinger, Sarah D; Fokkema, Angelique; Aceto, Nicola; Bernhardt, Peter; van der Meulen, Nicholas P; Müller, Cristina; Wild, Damian; Schibli, Roger

Evaluation of the Performance of Newborn Screening for Tyrosinemia Type 1 in The Netherlands: Suggestions for Improvements Using Additional Biomarkers in Addition to Succinylacetone

荷兰新生儿酪氨酸血症1型筛查性能评估:除琥珀酰丙酮外,使用其他生物标志物改进筛查的建议

Bouva, Marelle J; Kuypers, Allysa M; Kemper, Evelien A; Maase, Rose E; Bosch, Annet M; van Spronsen, Francjan J; Heijboer, Annemieke C; Heiner-Fokkema, M Rebecca; Heil, Sandra G; Boelen, Anita

Correction: Kuypers et al. Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide. Int. J. Neonatal Screen. 2024, 10, 82

更正:Kuypers 等人,《全球新生儿酪氨酸血症 1 型筛查项目的评估》,《国际新生儿筛查杂志》,2024 年,第 10 卷,第 82 页。

Kuypers, Allysa M; Bouva, Marelle J; Loeber, J Gerard; Boelen, Anita; Dekkers, Eugenie; Petritis, Konstantinos; Pickens, C Austin; The Isns Representatives; van Spronsen, Francjan J; Heiner-Fokkema, M Rebecca

Too Early to Tell? Balancing Diagnostic Accuracy of Newborn Screening for Propionic Acidemia Versus a Timely Referral

现在下结论还为时过早吗?新生儿丙酸血症筛查的诊断准确性与及时转诊之间的平衡

Meijer, Nils W F; Huidekoper, Hidde H; Koop, Klaas; Fuchs, Sabine A; Heiner Fokkema, M Rebecca; Lubout, Charlotte M A; Haijer-Schreuder, Andrea B; Visser, Wouter F; Verschoof-Puite, Rendelien K; Dekkers, Eugènie; Bosch, Annet M; Maase, Rose E; de Sain-van der Velden, Monique G M